ROIV Revenue second quarter 2026 Y/Y Growth Comment
Roivant Sciences Ltd achieved in the second quarter 2026, above Company average Revenue surge of 2137.01% year on year, to $ 35.12 millions.
Looking into second quarter 2026 results within Major Pharmaceutical Preparations industry 174 other companies have achieved higher Revenue growth. While Roivant Sciences Ltd ' s Revenue doubling of 2137.01% ranks overall at the positon no. 3695 in the second quarter 2026.
Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026
Roivant Sciences Ltd 's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
334.62 %
36.6 %
-91.88 %
(Dec 31 2020)
ROIV's II. Quarter Q/Q Revenue Comment
Roivant Sciences Ltd achieved in the II. Quarter 2026 above company average sequential Revenue doubling of 2338.96%, to $ 35.12 millions, from $1.44 millions in the first quarter. ROIV is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Major Pharmaceutical Preparations industry 176 other companies have achieved higher Revenue quarter on quarter growth. While Roivant Sciences Ltd 's Revenue growth quarter on quarter, overall rank is 3624.
Roivant Sciences Ltd achieved in the II. Quarter 2026 above company average sequential Revenue doubling of 2338.96%, to $ 35.12 millions, from $1.44 millions in the first quarter. ROIV is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Major Pharmaceutical Preparations industry 176 other companies have achieved higher Revenue quarter on quarter growth. While Roivant Sciences Ltd 's Revenue growth quarter on quarter, overall rank is 3624.
Roivant Sciences Ltd 's 12 Months Revenue Growth Year on Year
Roivant Sciences Ltd showed decline, but improvement compare to trailing twelve month Revenue decrease in Mar 31 2026. If the fiscal year would end in Jun 30 2026, Roivant Sciences Ltd 's annual Revenue decrease would be -67.58% year on year to $8 millions.
In the Healthcare sector 529 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 3727.
Roivant Sciences Ltd showed decline, but improvement compare to trailing twelve month Revenue decrease in Mar 31 2026. If the fiscal year would end in Jun 30 2026, Roivant Sciences Ltd 's annual Revenue drop would be -67.58% year on year to $8 millions.
In the Healthcare sector 529 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 3727.
About Roivant Sciences Ltd Revenue Growth Rates (ROIV), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
2,356.46%